Anti - TGF - beta receptor type II single domain antibodies

Details for Australian Patent Application No. 2010277629 (hide)

Owner Glaxo Group Limited

Inventors De Wildt, Rudolf Maria; Dimech, Caroline J.; Holmes, Steve; Stoop, Adriaan Allart

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010277629

PCT Pub. Number WO2011/012609

Priority 61/229,334 29.07.09 US

Filing date 27 July 2010

Wipo publication date 3 February 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

Event Publications

16 February 2012 PCT application entered the National Phase

  PCT publication WO2011/012609 Priority application(s): WO2011/012609

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010277657-Subcutaneous anti-HER2 antibody formulation

2010277627-Energy management in a building